Michael Schleuning

Sorafenib Maintenance After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia With <i>FLT3</i>–Internal Tandem Duplication Mutation (SORMAIN)

Andreas Burchert, Gesine Bug, Lea Fritz et al. · Journal of Clinical Oncology · 2020 · 538 citations · Full text

Sequential Regimen of Chemotherapy, Reduced-Intensity Conditioning for Allogeneic Stem-Cell Transplantation, and Prophylactic Donor Lymphocyte Transfusion in High-Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome

Christoph Schmid, Michael Schleuning, Georg Ledderose et al. · Journal of Clinical Oncology · 2005 · 415 citations

Consensus Conference on Clinical Practice in Chronic GVHD: Second-Line Treatment of Chronic Graft-versus-Host Disease

Daniel Wolff, Michael Schleuning, Stephanie von Harsdorf et al. · Biology of Blood and Marrow Transplantation · 2010 · 329 citations · Full text

Cell Therapy, Immunology, Biological Therapy +22

Modulation of acute graft-versus-host-disease after allogeneic bone marrow transplantation by tumor necrosis factor alpha (TNF alpha) release in the course of pretransplant conditioning: role of conditioning regimens and prophylactic application of a monoclonal antibody neutralizing human TNF alpha (MAK 195F)

Ernst Holler, HJ Kolb, J. Mittermüller et al. · Blood · 1995 · 195 citations · Full text

Impact of human herpesvirus‐6 after haematopoietic stem cell transplantation

Marcus Hentrich, Daniel Oruzio, Gundula Jäger et al. · British Journal of Haematology · 2004 · 151 citations